JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 102 filers reported holding JUNO THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $41,859,000 | +1.9% | 915,750 | 0.0% | 0.26% | +7.5% |
Q3 2017 | $41,081,000 | +50.1% | 915,750 | 0.0% | 0.24% | +35.8% |
Q2 2017 | $27,372,000 | +34.7% | 915,750 | 0.0% | 0.18% | +15.8% |
Q1 2017 | $20,320,000 | +17.7% | 915,750 | 0.0% | 0.15% | +10.1% |
Q4 2016 | $17,262,000 | -37.2% | 915,750 | 0.0% | 0.14% | -38.1% |
Q3 2016 | $27,482,000 | -21.9% | 915,750 | 0.0% | 0.22% | -18.9% |
Q2 2016 | $35,201,000 | +0.9% | 915,750 | 0.0% | 0.28% | 0.0% |
Q1 2016 | $34,881,000 | -13.4% | 915,750 | 0.0% | 0.28% | -10.1% |
Q4 2015 | $40,266,000 | +8.1% | 915,750 | 0.0% | 0.31% | -13.6% |
Q3 2015 | $37,262,000 | -23.7% | 915,750 | 0.0% | 0.35% | +16.1% |
Q2 2015 | $48,837,000 | -12.1% | 915,750 | 0.0% | 0.30% | -26.7% |
Q1 2015 | $55,549,000 | +16.2% | 915,750 | 0.0% | 0.42% | -16.3% |
Q4 2014 | $47,820,000 | – | 915,750 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|